Pharmaids Pharmaceuticals Sells 66.5% Stake in Anugraha Chemicals for ₹6.65 Lakh

Mumbai, September 19, 2025 – Pharmaids Pharmaceuticals Ltd (BSE: 524572) went up 1.07% to ₹55.93 at 2:15 PM on Friday after the firm said it will sell its whole 66.50% partnership holding in Anugraha Chemicals for a cash consideration of ₹6.65 lakh.

The exit, carried out under an Exit and Reconstitution Deed on 18th September, 2025, results in Anugraha Chemicals no longer being a material subsidiary of Pharmaids. The deal had been previously approved by shareholders through postal ballot on 14th August, 2025.

Key Transaction Details

Pharmaids Pharmaceuticals has offloaded its 66.50% shareholding in Anugraha Chemicals for an amount of ₹6.65 lakh on September 18, 2025. The shareholding was offloaded to Mrs. Sneha Hadimani as nominee of Mr. Sourabh Hadimani.

Upon the disposal, Anugraha Chemicals has no longer been a material subsidiary of Pharmaids Pharmaceuticals. The company explained that the transaction was done on an arm’s length basis without the involvement of related parties.

Financial Contribution of Anugraha Chemicals (FY25)

In FY25, Anugraha Chemicals supported Pharmaids Pharmaceuticals’ consolidated performance considerably. The subsidiary accounted for ₹13.40 crore of topline, which was 68.91% of the consolidated topline of the company. On the balance sheet front, Anugraha Chemicals contributed ₹3.74 crore to net worth, which was 6.80% of the consolidated net worth.

The company also ended its previous Investment Agreement (January 2023) with Anugraha Chemicals and co-shareholder Mr. Sourabh Hadimani, thus cutting off all previous contractual connections.

Stock Performance

Pharmaids Pharmaceuticals stock is trading at ₹55.93, a 1.07% increase on September 19, 2025 at 2:15 PM IST. Pharmaids Pharmaceuticals Ltd. shares opened at ₹53.75 and rose to an intraday high of ₹57.79, while the day’s low was at ₹53.75. The market capitalization of the company is estimated at ₹197.39 crore. The stock has moved between a 52-week low of ₹31.90 and a 52-week high of ₹87.46 over the last year.

The BSE-listed Pharmaids Pharmaceuticals Ltd is in the business of pharmaceuticals with emphasis on healthcare formulations. The firm, which was formed in 1989 and is headquartered in Bengaluru, has been restructuring its portfolio to consolidate operations.

REF: https://www.bseindia.com/xml-data/corpfiling/AttachLive/267111c0-4fc1-4a1b-bb34-e31e0064e53c.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations